Patient-centered Assessment of the Effects of Powered Exoskeleton Use in People With Spinal Cord Injury
NCT ID: NCT05811884
Last Updated: 2025-05-02
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
SUSPENDED
NA
18 participants
INTERVENTIONAL
2026-01-31
2031-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
1. How much does the use of powered exoskeleton improve the quality of life in subjects with spinal cord injury after a 24 months treatment period in a house context (treatment 1) or in a clinical setting (treatment 2)?
2. How much do the two treatments differ in terms of cost-utility ratio?
Participants will be included in a multi-step process consisting of:
1. Recruitment, based on eligibility criteria;
2. Observation of the "stability" over time (2 months) of specific clinical parameters;
3. Training in the use of the powered exoskeleton (1 month);
4. Random selection of the rehabilitation treatment (house rehabilitation or central rehabilitation); concerning the house rehabilitation, the subject will be provided the device for home use; concerning the central rehabilitation, the subject will be asked to use intensively the device 1-week every three months in a clinical facility.
5. Follow-up: every six months each subject will be asked to attend a single-day activities session consisting of walking activities with the exoskeleton, compilation of questionnaires, sub-maximal effort test with arm-ergometer, and physical examinations made by a physiatrist.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Restoring Walking With a Powered Exoskeleton After Spinal Cord Injury
NCT02322125
Performance Attributes and User Progression While Using Ekso
NCT02132702
Non-Ambulatory SCI Walk Using a Robotic Exoskeleton: Effect on Bone and Muscle
NCT02324322
Exoskeleton and Spinal Cord Stimulation for SCI
NCT03096197
Effectiveness of a Powered Exoskeleton Combined With FES for Patients With Chronic SCI: a RCT
NCT05187650
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
House rehabilitation
The subjects will be provided of the powered exoskeleton for home use. No specific indications will be provided, but using the technology as much as possible.
Every six months, the subjects will be asked to attend a single-day session by the clinical facility (follow-up session) consisting on the assessement of a series of qualitative and quantitative measurements.
Rehabilitation
The subjects will be provided of the powered exoskeleton for home use. No specific indications will be provided, but using the technology as much as possible.
The subjects will be asked to attend to periodic rehabilitation sessions by the clinical facility. The rehabilitation session will consist in an intense 1-week activities session every three months.
Every six months, the subjects will be asked to attend a single-day session by the clinical facility (follow-up session) consisting on the assessement of a series of qualitative and quantitative measurements.
Central rehabilitation
The subjects will be asked to attend to periodic rehabilitation sessions by the clinical facility. The rehabilitation session will consist in an intense 1-week activities session every three months. Every six months, the subjects will be asked to attend a single-day session by the clinical facility (follow-up session) consisting on the assessement of a series of qualitative and quantitative measurements.
Rehabilitation
The subjects will be provided of the powered exoskeleton for home use. No specific indications will be provided, but using the technology as much as possible.
The subjects will be asked to attend to periodic rehabilitation sessions by the clinical facility. The rehabilitation session will consist in an intense 1-week activities session every three months.
Every six months, the subjects will be asked to attend a single-day session by the clinical facility (follow-up session) consisting on the assessement of a series of qualitative and quantitative measurements.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Rehabilitation
The subjects will be provided of the powered exoskeleton for home use. No specific indications will be provided, but using the technology as much as possible.
The subjects will be asked to attend to periodic rehabilitation sessions by the clinical facility. The rehabilitation session will consist in an intense 1-week activities session every three months.
Every six months, the subjects will be asked to attend a single-day session by the clinical facility (follow-up session) consisting on the assessement of a series of qualitative and quantitative measurements.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age between 18 and 65 years;
* Body weight lower than 113 Kg;
* Level of spinal lesion T4 and higher;
* Integrity of upper limbs (strength and range of motion assessed by a clinical operator);
* Abbreviated Injury Scale (AIS) score A or B;
* Number of months after lesion higher than 6;
* Anthropometry in conformity with the declarations of exoskeleton's manufacturers.
Exclusion Criteria
* Use of colostomy bag;
* The subject is pregnant/ nursing;
* Presence of cognitive impairments;
* Presence of severe neurologic lesions in addition to SCI (sclerosis, cerebral palsy or trauma,…);
* Severe comorbidities;
* Uncontrolled hypertension or orthostatic hypotension;
* Uncontrolled autonomic dysreflexia;
* Problems at the skeletal system: T-score of femoral neck lower than -3 (DEXA examination is required), bone mineral density of proximal tibia or distal femur lower than 0.6 g/cm2, presence of non-recovered fractures, ectopic ossification, unstable spine;
* Kinesiologic impairments of the lower limbs: Ashworth spasticity of hamstrings, quadriceps, gastrocnemius muscles (right/ left) lower than 4, uncontrolled clonic spasm, pathologic contractures: non conformity of the range of motion of ankle/ knee/ hip with the requisites for use of powered exoskeletons for ambulation, presence of pressure lesions, dysmetria: femurs higher than 1.5 cm/ tibias higher than 2 cm;
* Kinesiologic impairments of the upper limbs: limitations at the joints, weakness of shoulder/ elbow/ hand (manual evaluation by a clinician), no autonomy in transfers;
* Weak control of the trunk;
* Inability to stand for at least 30 minutes;
* Presence of joint prostheses in upper and lower limbs;
* Use of drugs that may affect cognition and coordination while using the exoskeleton.
18 Years
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Istituto Nazionale Assicurazione contro gli Infortuni sul Lavoro
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Centro Protesi Inail
Budrio, Bologna, Italy
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
SSC DCAPR Prospettico
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.